Ana Graf

3.6k citations
39 papers · 1.9k indexed · 1 hit paper · h-index 14

Impact in

    • Tryptophan and brain disorders
  • Neurology top 2%
    • Neuroinflammation and Neurodegeneration Mechanisms
    • Parkinson's Disease Mechanisms and Treatments

Papers in

Ana Graf

37 papers receiving 1.8k citations

Hit Papers

Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup 2024 · 776 citations
776202420262025250500750

Peers

Ana Graf
Comparison fields: 5 of 110
  • Biological Psychiatry 132
  • Neurology 350
  • Psychiatry and Mental health 610
  • Physiology 1.0k
  • Pharmacology 322
Replace Paul Ardayfio with:
Paul Ardayfio United States
Tiffini Voss United States
JonDavid Sparks United States
Mikko Hölttä Sweden
Petroula Proitsi United Kingdom
Giovanni B. Frisoni Switzerland
Joseph Therriault Canada
Juan Manuel Maler Germany
Keith M. Gregg United States
Kina Höglund Sweden
Ana Graf relative to Paul Ardayfio United States Paul Ardayfio's profile →
Citations per field
00.5×5.4×
Paul Ardayfio · 1×
Citations per year

Countries citing papers authored by Ana Graf

Since Specialization
Citations

This map shows the geographic impact of Ana Graf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Graf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Graf more than expected).

Fields of papers citing papers by Ana Graf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Graf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Graf. The network helps show where Ana Graf may publish in the future.

Co-authors

The 25 scholars most cited alongside Ana Graf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ana Graf Line = papers co-authored together Ana Graf links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20251
3 20246
4 20243
5
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Hit paper breakdown →
2024776
6 202318
7 20233
8 20233
9 20202
10 202024
11 20171
12 201653
13 2015106
14 201468
15 20142
16 20141
17 201344
18 2012234
19 201135
20 200545

About Ana Graf

Ana Graf is a scholar working on Physiology, Psychiatry and Mental health, Pharmacology, Neurology and Computational Theory and Mathematics, having authored 39 papers that have together received 1.9k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (28 papers), Cholinesterase and Neurodegenerative Diseases (15 papers), Dementia and Cognitive Impairment Research (13 papers), Computational Drug Discovery Methods (8 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Neurological disorders and treatments (3 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). The work is most often cited by research in Biological Psychiatry (132 citations), Neurology (350 citations), Psychiatry and Mental health (610 citations), Physiology (1.0k citations) and Pharmacology (322 citations). Ana Graf has collaborated with scholars based in Switzerland, United States and Sweden. Frequent co-authors include Philip Scheltens, Niels Andreasen, Bengt Winblad, Charlotte E. Teunissen, Oskar Hansson, William J. Jagust, José Luís Molinuevo, Marı́a C. Carrillo, Clifford R. Jack and Michael S. Rafii. Their work appears in journals such as Alzheimer s & Dementia, Alzheimer s & Dementia Translational Research & Clinical Interventions, Alzheimer s Research & Therapy, Movement Disorders and The Lancet Healthy Longevity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026